Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This is a pilot that will evaluate two regimens for treating HIV infected patients that
haven't been on treatment before. HIV/AIDS patients may have an increased risk of myocardial
infarction and antiretroviral therapy used may contribute to this. We will evaluate
virological, immunological and cardiovascular effects of two HIV treatment regimens.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston